CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Oscotec Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Oscotec Inc
700, Daewangpangyo-ro, Bundang-gu
Phone: +82 316287613p:+82 316287613 SEONGNAM, 13488  South Korea Ticker: 039200039200
Business Summary
Oscotec Inc is a Korea-based company primarily engaged in new drug development business. The Company mainly researches and develops synthetic new drugs, including therapies for autoimmune diseases, acute myeloid leukemia, refractory solid tumors, Alzheimer’s disease and next-generation solid tumor treatments designed to overcome drug resistance. In addition, the Company operates functional materials and related products business, as well as dental bone graft materials business. The functional materials and related product business mainly provides functional materials for osteoporosis prevention and bone health, materials and finished products for the prevention and relief of arthritis, as well as functional materials for the prevention and relief of periodontal diseases. The dental bone graft materials business mainly offers bone graft materials and barrier membranes.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202512/31/2025Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
8731 Commercial physical and biological research
5149 Groceries and related products, not elsewhere classified
2099 Food preparations, not elsewhere classified
5999 Miscellaneous retail stores, not elsewhere classified
5141 Groceries, general line

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Co-Chief Executive Officer, Director Sang HyeonLee 53 4/14/2025
Co-Chief Executive Officer, Director Tae YeongYoon 63 4/14/2025 3/26/2020
Vice President, Director Yeong SinGwak 56 3/27/2025 3/27/2025
4 additional Officers and Directors records available in full report.

Business Names
Business Name
0392
039200
Oscotec Inc.

General Information
Number of Employees: 35 (As of 3/31/2015)
Outstanding Shares: 38,258,176 (As of 12/31/2025)
Shareholders: 53,420
Stock Exchange: KDQ
Fax Number: +82 316287615


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, April 11, 2026